Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 115

1.

Glycogen synthase kinase-3β genetic polymorphisms and insomnia in depressed patients: A prospective study.

Costemale-Lacoste JF, Colle R, Martin S, Asmar KE, Loeb E, Feve B, Verstuyft C, Trabado S, Ferreri F, Haffen E, Polosan M, Becquemont L, Corruble E.

J Affect Disord. 2018 Nov;240:230-236. doi: 10.1016/j.jad.2018.07.062. Epub 2018 Jul 24.

PMID:
30081294
2.

The functional variant rs334558 of GSK3B is associated with remission in patients with depressive disorders.

Levchenko A, Losenkov IS, Vyalova NM, Simutkin GG, Bokhan NA, Wilffert B, Loonen AJ, Ivanova SA.

Pharmgenomics Pers Med. 2018 Jul 20;11:121-126. doi: 10.2147/PGPM.S171423. eCollection 2018.

3.

Gene-based analysis of genes related to neurotrophic pathway suggests association of BDNF and VEGFA with antidepressant treatment-response in depressed patients.

Kao CF, Liu YL, Yu YW, Yang AC, Lin E, Kuo PH, Tsai SJ.

Sci Rep. 2018 May 3;8(1):6983. doi: 10.1038/s41598-018-25529-y.

4.

An Oldie but Goodie: Lithium in the Treatment of Bipolar Disorder through Neuroprotective and Neurotrophic Mechanisms.

Won E, Kim YK.

Int J Mol Sci. 2017 Dec 11;18(12). pii: E2679. doi: 10.3390/ijms18122679. Review.

5.

Therapeutic role of long non-coding RNA TCONS_00019174 in depressive disorders is dependent on Wnt/β-catenin signaling pathway.

Ni X, Liao Y, Li L, Zhang X, Wu Z.

J Integr Neurosci. 2018;17(2):203-215. doi: 10.3233/JIN-170052.

PMID:
29036835
6.

Gsk3β aggravates the depression symptoms in chronic stress mouse model.

Peng H, Wang HB, Wang L, Zhou B, Li XY, Tan J.

J Integr Neurosci. 2018;17(2):217-226. doi: 10.3233/JIN-170050.

PMID:
29036833
7.

Failure to Inactivate Nuclear GSK3β by Ser389-Phosphorylation Leads to Focal Neuronal Death and Prolonged Fear Response.

Thornton TM, Hare B, Colié S, Pendlebury WW, Nebreda AR, Falls W, Jaworski DM, Rincon M.

Neuropsychopharmacology. 2018 Jan;43(2):393-405. doi: 10.1038/npp.2017.187. Epub 2017 Aug 17.

PMID:
28832021
8.

Precision medicine for suicidality: from universality to subtypes and personalization.

Niculescu AB, Le-Niculescu H, Levey DF, Phalen PL, Dainton HL, Roseberry K, Niculescu EM, Niezer JO, Williams A, Graham DL, Jones TJ, Venugopal V, Ballew A, Yard M, Gelbart T, Kurian SM, Shekhar A, Schork NJ, Sandusky GE, Salomon DR.

Mol Psychiatry. 2017 Sep;22(9):1250-1273. doi: 10.1038/mp.2017.128. Epub 2017 Aug 15.

9.

Oxidative stress with tau hyperphosphorylation in memory impaired 1,2-diacetylbenzene-treated mice.

Kang SW, Kim SJ, Kim MS.

Toxicol Lett. 2017 Sep 5;279:53-59. doi: 10.1016/j.toxlet.2017.07.892. Epub 2017 Jul 20.

PMID:
28734998
10.

Corrigendum to "The GSK3B gene confers risk for both major depressive disorder and schizophrenia in the Han Chinese population" [J. Affect. Disord. 185 (2015) 149-155].

Chen J, Wang M, Khan RAW, He K, Wang Q, Li Z, Shen J, Song Z, Li W, Wen Z, Jiang Y, Xu Y, Shi Y, Ji W.

J Affect Disord. 2017 Oct 15;221:267. doi: 10.1016/j.jad.2017.06.018. No abstract available.

PMID:
28662458
11.

The interaction of GSK3B and FXR1 genotypes may influence the mania and depression dimensions in mood disorders.

Bureau A, Beaulieu JM, Paccalet T, Chagnon YC, Maziade M.

J Affect Disord. 2017 Apr 15;213:172-177. doi: 10.1016/j.jad.2017.02.023. Epub 2017 Feb 16.

PMID:
28242499
12.

The genetic overlap between mood disorders and cardiometabolic diseases: a systematic review of genome wide and candidate gene studies.

Amare AT, Schubert KO, Klingler-Hoffmann M, Cohen-Woods S, Baune BT.

Transl Psychiatry. 2017 Jan 24;7(1):e1007. doi: 10.1038/tp.2016.261. Review.

13.

The gender-specific association of rs334558 in GSK3β with major depressive disorder.

Liu S, Wang L, Sun N, Yang C, Liu Z, Li X, Cao X, Xu Y, Zhang K.

Medicine (Baltimore). 2017 Jan;96(3):e5928. doi: 10.1097/MD.0000000000005928.

14.

Overexpression of βCaMKII impairs behavioral flexibility and NMDAR-dependent long-term depression in the dentate gyrus.

Yin P, Xu H, Wang Q, Wang J, Yin L, Xu M, Xie Z, Liu W, Cao X.

Neuropharmacology. 2017 Apr;116:270-287. doi: 10.1016/j.neuropharm.2016.12.013. Epub 2016 Dec 16.

PMID:
27993520
15.

Role of neurodevelopment involved genes in psychiatric comorbidities and modulation of inflammatory processes in Alzheimer's disease.

Porcelli S, Crisafulli C, Donato L, Calabrò M, Politis A, Liappas I, Albani D, Atti AR, Salfi R, Raimondi I, Forloni G, Papadimitriou GN, De Ronchi D, Serretti A.

J Neurol Sci. 2016 Nov 15;370:162-166. doi: 10.1016/j.jns.2016.09.053. Epub 2016 Sep 28. Erratum in: J Neurol Sci. 2017 Jan 15;372:49.

PMID:
27772752
16.

Antinociceptive and Anti-Inflammatory Effects of Ketamine and the Relationship to Its Antidepressant Action and GSK3 Inhibition.

do Vale EM, Xavier CC, Nogueira BG, Campos BC, de Aquino PE, da Costa RO, Leal LK, de Vasconcelos SM, Neves KR, de Barros Viana GS.

Basic Clin Pharmacol Toxicol. 2016 Dec;119(6):562-573. doi: 10.1111/bcpt.12637. Epub 2016 Aug 23.

17.

Hippocampal MicroRNA-124 Enhances Chronic Stress Resilience in Mice.

Higuchi F, Uchida S, Yamagata H, Abe-Higuchi N, Hobara T, Hara K, Kobayashi A, Shintaku T, Itoh Y, Suzuki T, Watanabe Y.

J Neurosci. 2016 Jul 6;36(27):7253-67. doi: 10.1523/JNEUROSCI.0319-16.2016.

18.

Towards understanding and predicting suicidality in women: biomarkers and clinical risk assessment.

Levey DF, Niculescu EM, Le-Niculescu H, Dainton HL, Phalen PL, Ladd TB, Weber H, Belanger E, Graham DL, Khan FN, Vanipenta NP, Stage EC, Ballew A, Yard M, Gelbart T, Shekhar A, Schork NJ, Kurian SM, Sandusky GE, Salomon DR, Niculescu AB.

Mol Psychiatry. 2016 Jun;21(6):768-85. doi: 10.1038/mp.2016.31. Epub 2016 Apr 5.

PMID:
27046645
19.

Repeated Three-Hour Maternal Separation Induces Depression-Like Behavior and Affects the Expression of Hippocampal Plasticity-Related Proteins in C57BL/6N Mice.

Bian Y, Yang L, Wang Z, Wang Q, Zeng L, Xu G.

Neural Plast. 2015;2015:627837. doi: 10.1155/2015/627837. Epub 2015 Dec 22.

20.

Activation of a synapse weakening pathway by human Val66 but not Met66 pro-brain-derived neurotrophic factor (proBDNF).

Kailainathan S, Piers TM, Yi JH, Choi S, Fahey MS, Borger E, Gunn-Moore FJ, O'Neill L, Lever M, Whitcomb DJ, Cho K, Allen SJ.

Pharmacol Res. 2016 Feb;104:97-107. doi: 10.1016/j.phrs.2015.12.008. Epub 2015 Dec 11.

Supplemental Content

Loading ...
Support Center